A study in patients with HER2-positive breast cancer that has spread and has not responded to one course of anti-cancer therapy

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-001628-37

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to evaluate the safety and tolerability of trastuzumab emtansine.


Critère d'inclusion

  • HER2 positive metastatic breast cancer